Product Information
URSODIOL 250 MG TABLET is a generic product labeled by Endo USA Inc., priced at $0.4495 per EA under NDC 49884041201. Its NADAC has been published 656 times since Mar 12, 2014.
FDA first approved this application on Feb 14, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Endo USA Inc.NDC
49884041201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
URSODIOLApproval Type
Generic (ANDA)
FDA Application
ANDA202540FDA Approved
2/14/2013
TE Code
AB
On Market Since
8/1/2013
Pharmacological Classes
Price Statistics
The NADAC for URSODIOL 250 MG TABLET has been published 656 times since Mar 12, 2014, and over the history we have for it it has declined 69.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4495 per EA |
|---|---|
| All-time high | $1.7992 (Aug 12, 2015) |
| All-time low | $0.2571 (Jul 17, 2024) |
| 52-week high | $0.4550 |
| 52-week low | $0.3403 |
| Median price | $0.8425 |
| Average price | $0.8880 |
| Largest weekly change | +77.9% (Aug 21, 2024) |
| Weeks tracked | 656 |
| Tracking since | Mar 12, 2014 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Endo USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ursodiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bile Acid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of URSODIOL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for URSODIOL 250 MG TABLET, manufactured by Endo USA Inc., is $0.4495 per EA (NDC 49884041201), effective Sep 30, 2026.
How has the price of URSODIOL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for URSODIOL 250 MG TABLET has declined 69.4%. It has been tracked across 656 weekly CMS publications since Mar 12, 2014.
What are the highest and lowest recorded NADAC prices for URSODIOL 250 MG TABLET?
Since Mar 12, 2014, the NADAC for URSODIOL 250 MG TABLET has ranged from a low of $0.2571 (Jul 17, 2024) to a high of $1.7992 (Aug 12, 2015), with a median of $0.8425 per EA.
Are there cheaper alternatives to URSODIOL 250 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, URSODIOL 250 MG TABLET, is $0.4295 per EA — about 4% below URSODIOL 250 MG TABLET.
Who manufactures URSODIOL 250 MG TABLET?
URSODIOL 250 MG TABLET (NDC 49884041201) is labeled by Endo USA Inc., and CMS classifies it as a generic product.